Cognitive and Psychological Disorders After Severe COVID-19 Infection

NACompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

August 23, 2021

Primary Completion Date

September 27, 2023

Study Completion Date

September 27, 2023

Conditions
COVID 19
Interventions
DIAGNOSTIC_TEST

Cognitive assessment

Complete cognitive and psychological assessment

DIAGNOSTIC_TEST

Imaging

"Brain MRI~Optional: Brain FDG PET (Brain positron emission tomography with F-18 fluorodeoxyglucose)"

DIAGNOSTIC_TEST

Routine care

"Electroencephalogram (EEG)~Optional: polysomnography, lumbar puncture"

OTHER

Psychiatric evaluation

Psychiatric consultation if necessary

OTHER

Psychiatric evaluation

Psychiatric consultation if necessary (before the end of their participation in the study)

Trial Locations (1)

54000

Nancy University Hospital, Department of Neurology, Nancy

All Listed Sponsors
collaborator

Centre Hospitalier Universitaire de Besancon

OTHER

collaborator

University Hospital, Strasbourg, France

OTHER

collaborator

Centre Hospitalier Régional Metz-Thionville

OTHER

collaborator

Centre hospitalier Epinal

UNKNOWN

collaborator

Hopitaux Civils de Colmar

OTHER

lead

Central Hospital, Nancy, France

OTHER

NCT04937582 - Cognitive and Psychological Disorders After Severe COVID-19 Infection | Biotech Hunter | Biotech Hunter